Waltham, MA, United States of America

Ronald Scharf

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Ronald Scharf

Introduction

Ronald Scharf is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 7 patents, Scharf has focused on systems and methods that enhance the monitoring of photo-active agents in the eye.

Latest Patents

One of Scharf's latest patents involves systems and methods for monitoring time-based photo-active agent delivery or photo-active marker presence in an eye. This monitoring system measures the presence of a photo-active marker by illuminating the eye to excite the marker and observing the characteristic emission. The systems utilize Scheimpflug optical systems or slit lamp optical systems to capture cross-sectional images of the eye. This allows for the monitoring of instantaneous distribution, diffusion patterns, and the rate of uptake of a photo-active agent applied to the eye. Furthermore, these systems can utilize the monitored distribution of the photo-active agent as feedback for a cross-linking system.

Career Highlights

Scharf's career is marked by his dedication to advancing eye care technology. His work at Avedro, Inc. has positioned him as a leader in the development of innovative solutions for eye treatment. His patents reflect a commitment to improving patient outcomes through technology.

Collaborations

Throughout his career, Scharf has collaborated with notable colleagues, including David Muller and Thomas Ryan. These partnerships have contributed to the development of his innovative technologies.

Conclusion

Ronald Scharf's contributions to the field of ophthalmology through his patents demonstrate his commitment to innovation and improving eye care. His work continues to influence the industry and enhance patient treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…